SCHEMBL13454473

SCHEMBL13454473

Cc1cccc(C)c1NS(=O)(=O)c1ccc(NC(=S)NC(=O)c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.68
ALOX12 P18054 5/20 0.68
THRB P10828 1/20 0.68
GPR55 Q9Y2T6 5/20 0.66
CA1 P00915 2/20 0.64
CA2 P00918 1/20 0.64
PLK1 P53350 1/20 0.64
CA9 Q16790 1/20 0.64
KMT2A Q03164 3/20 0.62
MEN1 O00255 2/20 0.62
LMNA P02545 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
MAPT P10636 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
HTT P42858 1/20 0.60
GAA P10253 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
RECQL P46063 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13454490 0.93 GPR55 (0.78) ALDH1A1ALOX12THRBGPR55KMT2A
SCHEMBL13454366 0.92 GPR55 (0.61) ALDH1A1ALOX12THRBGPR55KMT2A
SCHEMBL13453835 0.91 GPR55 (0.60) ALDH1A1ALOX12THRBGPR55CA1
SCHEMBL17066567 0.91 GPR55 (0.60) ALDH1A1ALOX12THRBGPR55CA1
SCHEMBL13454478 0.90 CA1 (0.64) ALDH1A1ALOX12THRBGPR55CA1
SCHEMBL13454466 0.90 ALDH1A1 (0.68) ALDH1A1ALOX12THRBGPR55CA1
SCHEMBL13453873 0.90 ALDH1A1 (0.63) ALDH1A1ALOX12THRBKMT2AMEN1
SCHEMBL13453808 0.89 ALDH1A1 (0.58) ALDH1A1ALOX12THRBGPR55KMT2A
SCHEMBL13470286 0.89 GPR55 (0.58) ALDH1A1ALOX12THRBGPR55CA1
SCHEMBL13454470 0.89 ALDH1A1 (0.68) ALDH1A1ALOX12THRBGPR55KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 US disclosed
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 US disclosed
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-10-18 US disclosed
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors PCTP, LCAT, CETP ALDH1A1 4289/4885ALOX12 2842/4885THRB 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.